The MRSA Detection Kit by Igenesis enables rapid and reliable identification of both Methicillin-Resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) using real-time multiplex fluorescence PCR. Compatible with the Galaxy Nano, Neo, Lite, and Pro systems, the assay targets the spa gene and the mecA resistance gene, delivering precise results from nasal, throat, or sputum samples.
Designed for use with the fully enclosed, automated iCassette system, the kit reduces contamination risk and streamlines workflow. Each iCassette comes preloaded with lyophilized primers and reagents for mecA (FAM), spa (CY5), and an internal control (HEX) to monitor assay performance.
With 12 ready-to-use reactions per kit and minimal hands-on time, this test is ideal for hospital laboratories, infection control programs, and molecular diagnostics teams requiring fast, actionable results for MRSA screening and antimicrobial stewardship.
The MRSA Detection Kit includes primers and probes targeting:
mecA gene – the genetic determinant of methicillin resistance (FAM channel)
spa gene – a conserved gene in Staphylococcus aureus used for identification (CY5 channel)
Internal control (HEX) – ensures PCR quality and flags inhibited or invalid results
Each kit contains 12 MRSA iCassettes, preloaded with:
Magnetic beads for extraction
Lysis, wash, and elution buffers
Lyophilized dNTPs, enzymes, primers, and probes
Positive and negative controls (pseudovirus with gene fragments)
NaOH pretreatment solution and enhancer for sputum processing
Samples are processed with minimal handling, directly within the sealed cassette system.
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of hospital- and community-acquired infections. Its resistance is conferred by the mecA gene, encoding PBP2a, which alters penicillin-binding affinity and confers resistance to β-lactam antibiotics.
The spa gene, encoding staphylococcal protein A, is universally present in S. aureus strains and is a reliable target for pathogen identification.
Together, detecting mecA-positive and spa-positive samples allows differentiation between:
MRSA-positive (mecA+, spa+)
Methicillin-sensitive SA (mecA–, spa+)
Negative or inhibited samples via internal control
This dual-target approach supports precise infection control, especially in respiratory surveillance and outbreak settings.
The Staphylococcus aureus and MRSA Drug-Resistance Gene Detection Kit by Igenesis is a CE-marked, professional-use-only test designed for enclosed, automated molecular diagnostics. It is compatible with Galaxy Nano, Neo, Lite, and Pro qPCR instruments.
Key specifications:
12 single-use iCassettes per kit
Validated for sputum, throat, and nasal swabs
No cross-reactivity with other major respiratory pathogens
LoD: 10³ copies/mL (molecular), 10³ CFU/mL (culture)
Precision: CV ≤ 5%
The kit includes all necessary reagents, controls, and instructions for direct sample-to-answer workflows. Once the cassette is loaded with sample and placed in the instrument, the process is fully automated from extraction to amplification and result output.
This MRSA PCR panel applies real-time multiplex PCR in a fully enclosed format. The test workflow includes:
Sample Preparation
Throat/nasal swabs: No pretreatment
Sputum: Mix with NaOH-based pretreatment solution + enhancer, liquefy fully
Cassette Loading & Ultrasonic Lysis
Add 1000 µL of sample into the iCassette
Sonicate for 20 seconds (or skip if using Galaxy Neo)
Automated PCR Run
Insert cassette → Scan QR code → Start run
Instrument auto-runs nucleic acid extraction, PCR, and fluorescence detection
Fluorescence Channels
FAM: mecA gene (MRSA)
CY5: spa gene (SA)
HEX: Internal control
Result Interpretation
Ct ≤ 37 = positive
HEX must be positive in negative samples
Invalid runs are automatically flagged by the system
Result output includes Ct values, amplification curves, and full interpretation summary directly in the software.
The MRSA Detection Kit supports use in:
Hospital microbiology labs for infection screening and outbreak control
ICU and emergency settings for rapid antimicrobial decision-making
Pre-surgical and admission screening for MRSA carriage
Infection prevention teams monitoring MRSA prevalence and colonization
Molecular diagnostics labs implementing closed-system, contamination-free workflows
Its dual-target design improves diagnostic clarity by distinguishing colonization from resistance, offering faster isolation decisions and improved patient outcomes.
IFU
For any missing information or if you require additional details, please do not hesitate to contact us.
Subscribe to our newsletter.